Search results

Filters
Close
ADDED DATE
Added date
AUTHOR Please select
TOPICS Please select
WATCH / LISTEN / READ TIME
Research Area(s) / Expertise:
Research Area(s) / Expertise:
ESC 23: The ILUMIEN IV Trial
Author(s): Ziad A Ali Added: 7 months ago
ESC 2023 — Dr Ziad Ali (DeMatteis St Francis, US) joins us to discuss the findings from the ILUMIEN IV clinical trial (NCT03507777). ILUMIEN IV (Abbott Medical Devices)is a prospective, single-blind clinical trial aiming to compare optical coherence tomography (OCT) to an angiography-guided stent implantation strategy. The trial investigated which method achieved a larger post-percutaneous… View more

Prevention & Chronic Conditions

MI/ACS
ESC 23: The STOPDAPT-3 Study
Author(s): Masahiro Natsuaki Added: 7 months ago
ESC 23 — Dr Masahiro Natsuaki (Saga University, JP) discusses the short and optimal duration of dual antiplatelet therapy-3 Study (STOPDAPT-3) (NCT04609111). In the STOPDAPT-2 study, 1-month dual antiplatelet therapy (DAPT) followed by clopidogrel monotherapy was shown to provide benefits in bleeding reduction over a 12-month period, however, other trials have shown high rates of bleeding at… View more

MI/ACS

Intervention
Andrew
Job title: Interventional Cardiologist
Dr Andrew Luckingis an InterventionalCardiologistat the John Radcliffe Hospital, Oxford. He has extensive experience in cardiac catheterization and intervention, primaryPCI,CTO, and intravascular imaging with IVUS and OCT. DrLucking has a well-established background in clinical research in interventional cardiology and is an expert in inflammatory mediators, thrombosis, and vascular injury… View more
Author(s): Diego Penela , Maríbel Diaz-Ricart , Magda Heras Added: 3 years ago
The usual underlying mechanism of acute coronary syndromes (ACSs) is a thrombotic event caused by the rupture or erosion of an atherosclerotic plaque. In this scenario, platelets and thrombin are key players. Thus, understanding the physiopathology of platelet activation is of paramount importance in the treatment of acute coronary ischaemia. There is ample evidence showing that adequate… View more

Anticoagulation

MI/ACS
Stefano Barco
Job title: Department of Angiology
Dr Stefano Barco completed his residency in internal medicine at the University of Pavia, Italy, and received a PhD in Vascular Medicine from the University of Amsterdam, the Netherlands. He leads a research group at the Center for Thrombosis and Hemostasis of the University Medical Center Mainz, Germany, and is staff physician at the Clinic of Angiology, University Hospital Zurich, Switzerland. View more